This downturn is different.
![](https://eckuity.com/wp-content/uploads/2022/06/bloomberg-radio.jpg)
Youssef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.
AGELESS THERAPEUTICS
Improving protein therapeutics through anti-glycation modification.
Youssef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.
Improving protein therapeutics through anti-glycation modification.